rendering of a globe and news stories

In the News

Outsourcing-Pharma (July 2019)

Five-year study to examine how healthy brains age: ‘Research is urgently needed,’ says AES

PPD business unit Accelerated Enrollment Solutions initiates the Synexus HealthyMinds Registry, which aims to register 30,000 adults for the study.

Outsourcing-Pharma
WRAL TechWire (July 2019)

PPD group launches major dementia study, to include 30,000 people

Dawie Wessels discusses the five-year study to explore ways to prevent and treat dementia.

techwire logo
Outsourcing-Pharma (July 2019)

PPD expands patient access to clinical trials via collaboration with cancer center

New collaboration expands opportunities for cancer patients to be treated in the community setting.

Outsourcing-Pharma
FierceBiotech (July 2019)

PPD teams up with Cancer Treatment Centers of America to boost oncology trials

Krystyna Kowalczyk explains that the collaboration creates meaningful opportunities for cancer patients to participate in clinical trials and access innovative therapies close to home

fierce biotech logo
Pharmaceutical Technology (June 2019)

Good laboratory practices: Getting on the same page

Stuart Jones discusses the importance of training and other factors that can significantly impact quality.

pharmaceutical technology logo
Applied Clinical Trials (June 2019)

De-risking master protocol implementation

Brian Barnes and Rachael Song provide an overview and discuss the benefits of master protocol studies.

applied clinical trials logo
BioPharm International (June 2019)

GLPs: Better data access needed to improve compliance

Stuart Jones shares his thoughts on good laboratory practices best practices.

BioPharm International
Applied Clinical Trials (June 2019)

Risk-based quality management: The importance of risk communication

Brian Barnes and Volker Hack discuss the ongoing efforts to encourage the implementation of improved and more efficient approaches to clinical trials.

applied clinical trials logo
FierceBiotech (June 2019)

PPD unit Evidera buys up real-world evidence company Medimix

The addition of Medimix will enhance Evidera’s ability to leverage data to provide real-world evidence and insights for clients.

fierce biotech logo